Literature DB >> 7507093

Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells.

T R Hughes1, S Meri, M Davies, J D Williams, B P Morgan.   

Abstract

CD59, a potent inhibitor of the human membrane attack complex (MAC) of complement, is present on many different tissues throughout the body. Recently we identified and characterized the rat analogue of CD59 and produced a number of monoclonal antibodies (mAb). We have now used these antibodies to demonstrate, by immunofluorescence microscopy, that rat CD59 was widely expressed in the rat kidney. Staining of renal sections revealed the presence of rat CD59 in abundance in the glomerulus, collecting ducts and distal tubules. Staining was abolished by treatment of sections with phosphatidylinositol-specific phospholipase C (PIPLC). Rat mesangial cells also stained strongly for rat CD59, giving an intensely granular staining pattern. In complement attack experiments the cultured mesangial cells were rendered more susceptible to lysis by rat or human complement after preincubation with the anti-inhibitor mAb. The results demonstrate that the rat analogue of CD59 is present and functionally active in rat renal tissue. The protective effect of CD59 against MAC-mediated tissue injury can now be examined in rat models of human renal disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507093      PMCID: PMC1422212     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

2.  Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol.

Authors:  I Stefanová; I Hilgert; H Kristofová; R Brown; M G Low; V Horejsí
Journal:  Mol Immunol       Date:  1989-02       Impact factor: 4.407

3.  Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.

Authors:  D H Lovett; J L Ryan; R B Sterzel
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.

Authors:  G Camussi; G Salvidio; G Biesecker; J Brentjens; G Andres
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

5.  Detection of terminal complement components in experimental immune glomerular injury.

Authors:  S Adler; P J Baker; P Pritzl; W G Couser
Journal:  Kidney Int       Date:  1984-12       Impact factor: 10.612

6.  Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells.

Authors:  S Adler; P J Baker; R J Johnson; R F Ochi; P Pritzl; W G Couser
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.

Authors:  S A Rollins; P J Sims
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

8.  Membrane attack complex deposition in experimental glomerular injury.

Authors:  D T Perkinson; P J Baker; W G Couser; R J Johnson; S Adler
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

9.  Activation of glomerular mesangial cells by the terminal membrane attack complex of complement.

Authors:  D H Lovett; G M Haensch; M Goppelt; K Resch; D Gemsa
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

10.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  3 in total

1.  Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.

Authors:  N K Rushmere; R A Harrison; C W van den Berg; B P Morgan
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

2.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

3.  Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.

Authors:  Silvia Ehrlenbach; Alejandra Rosales; Wilfried Posch; Doris Wilflingseder; Martin Hermann; Jens Brockmeyer; Helge Karch; Simon C Satchell; Reinhard Würzner; Dorothea Orth-Höller
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.